Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

National leaders in health, technology, education, and policy gathered Friday, Jan. 10, at the Crystal Bridges Museum of ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

What does Trump's decision to leave the WHO mean for public health? And should U.S. companies be intimidated by Chinese drug ...

A major conference that took place earlier this month is set to return to San Francisco next year, according to SF Mayor Daniel Lurie’s office. The J.P. Morgan ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

"We sit at the intersection of those large scale incumbents and entrepreneurs, to help bridge the gap," Josh Flum, Managing Partner at LRVHealth, tells Bloomberg Intelligence in this episode of the ...

In this conversation, the Business Journal invites Cadrenal Founder & CEO Quang Pham to talk about the biopharmaceutical ...

It’s always a good sign when a couple of big deals are announced right before the conference, and this year we saw a doozie ...

Healthcare finances have been steady in the past few months, and many healthcare provider's main focus is getting back to ...

During the conference call held on Tuesday, the focus is anticipated to be on the overall demand landscape, including the ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...